Determination of the glycemic threshold for the regression or prevention of diabetic microangiopathies, and the insulin injection regimen to establish strict glycemic control in NIDDM.
Kawamori
R
R
First Department of Medicine, Osaka University Medical School.
Kamada
T
T
D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D003925:Diabetic Angiopathies / Q000097:blood / Q000517:prevention & control* / Q000628:therapy; D006801:Humans; D007328:Insulin / Q000008:administration & dosage; D011446:Prospective Studies; D013453:Sulfonylurea Compounds / Q000627:therapeutic use
D001786:Blood Glucose; D007328:Insulin; D013453:Sulfonylurea Compounds